Gene · 259
Papers2,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL. | Cancer Immunol Immunother | 2021 | 34398302 | PubTator, text mining | PubMed |
Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic. | Am J Clin Nutr | 2021 | 34375388 | PubTator, text mining | PubMed |
| Maternal psychological distress, education, household income, and congenital heart defects: a prospective cohort study from the Japan environment and children's study. | BMC Pregnancy Childbirth | 2021 | 34364381 | PubTator, text mining | PubMed |
| Biomarkers in Cardiorenal Syndrome. | J Clin Med | 2021 | 34362216 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney disease. | J Transl Med | 2021 | 34332599 | PubTator, text mining | PubMed |
| Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model. | Gut Pathog | 2021 | 34330327 | PubTator, text mining | PubMed |
| MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. | J Immunother Cancer | 2021 | 34321275 | PubTator, text mining | PubMed |
| Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome. | Nat Commun | 2021 | 34315901 | PubTator, text mining | PubMed |
| Phase Stability of Iron Nitride Fe4N at High Pressure-Pressure-Dependent Evolution of Phase Equilibria in the Fe-N System. | Materials (Basel) | 2021 | 34300885 | PubTator, text mining | PubMed |
| Downregulation of Salivary Proteins, Protective against Dental Caries, in Type 1 Diabetes. | Proteomes | 2021 | 34287355 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity. | J Extracell Vesicles | 2021 | 34262673 | PubTator, text mining | PubMed |
| Live Imaging and Quantification of Neutrophil Extracellular Trap Formation. | Curr Protoc | 2021 | 34260822 | PubTator, text mining | PubMed |
| SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics. | ACS Omega | 2021 | 34250342 | PubTator, text mining | PubMed |
| Proteomic and Biological Analysis of an In Vitro Human Endothelial System in Response to Drug Anaphylaxis. | Front Immunol | 2021 | 34248989 | PubTator, text mining | PubMed |
| SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy. | Clin Chim Acta | 2021 | 34245688 | PubTator, text mining | PubMed |
| Influence of Dental Pulp Harvesting Method on the Viability and Differentiation Capacity of Adult Dental Pulp-Derived Mesenchymal Stem Cells. | Stem Cells Int | 2021 | 34239574 | PubTator, text mining | PubMed |
| Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications. | Mol Imaging Biol | 2021 | 34231103 | PubTator, text mining | PubMed |
| A serum proteome signature to predict mortality in severe COVID-19 patients. | Life Sci Alliance | 2021 | 34226277 | PubTator, text mining | PubMed |
| Development and validation of a nomogram for predicting severity in patients with hemorrhagic fever with renal syndrome: A retrospective study. | Open Med (Wars) | 2021 | 34222669 | PubTator, text mining | PubMed |
| Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis. | Front Genet | 2021 | 34220933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259/papers?page=32